Robert I. Blum - President & CEO, Director at Cytokinetics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
CYTK on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Robert I. Blum - trading volume in the past year for Cytokinetics Inc

Holdings reported by Robert I. Blum for Cytokinetics Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 350K $22.8M $65.02 Dec 3, 2025 Direct
Common Stock 2.08K $139K $66.50 Dec 3, 2025 by Trust 1
Common Stock 2.08K $139K $66.50 Dec 3, 2025 by Trust 2
Incentive Stock Option (Right to Buy) 2.25K $84.8K $37.63 Mar 14, 2025 Direct Common Stock
Non-Qualified Stock Option (Right to Buy) 177K Mar 14, 2025 Direct Common Stock

Transactions reported by Robert I. Blum for Cytokinetics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.